ATE253578T1 - Oxazinochinolone zur behandlung von viralen infektionen - Google Patents
Oxazinochinolone zur behandlung von viralen infektionenInfo
- Publication number
- ATE253578T1 ATE253578T1 AT00966694T AT00966694T ATE253578T1 AT E253578 T1 ATE253578 T1 AT E253578T1 AT 00966694 T AT00966694 T AT 00966694T AT 00966694 T AT00966694 T AT 00966694T AT E253578 T1 ATE253578 T1 AT E253578T1
- Authority
- AT
- Austria
- Prior art keywords
- oxazinoquinolones
- treatment
- viral infections
- infections
- viral
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15774299P | 1999-10-05 | 1999-10-05 | |
| PCT/US2000/021985 WO2001025239A2 (en) | 1999-10-05 | 2000-09-28 | Oxazinoquinolones useful for the treatment of viral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE253578T1 true ATE253578T1 (de) | 2003-11-15 |
Family
ID=22565065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00966694T ATE253578T1 (de) | 1999-10-05 | 2000-09-28 | Oxazinochinolone zur behandlung von viralen infektionen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6340680B1 (de) |
| EP (1) | EP1220858B1 (de) |
| JP (1) | JP2003511382A (de) |
| AR (1) | AR032598A1 (de) |
| AT (1) | ATE253578T1 (de) |
| AU (1) | AU773098B2 (de) |
| CA (1) | CA2382691A1 (de) |
| CO (1) | CO5251424A1 (de) |
| DE (1) | DE60006412T2 (de) |
| DK (1) | DK1220858T3 (de) |
| ES (1) | ES2210001T3 (de) |
| NZ (1) | NZ518189A (de) |
| PE (1) | PE20010598A1 (de) |
| PT (1) | PT1220858E (de) |
| TW (1) | TW500724B (de) |
| WO (1) | WO2001025239A2 (de) |
| ZA (1) | ZA200201556B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1299395B1 (de) * | 2000-07-12 | 2004-09-15 | PHARMACIA & UPJOHN COMPANY | Oxazinochinolone für die behandlung viraler infektionen |
| US6624159B2 (en) | 2000-07-12 | 2003-09-23 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| US6673793B2 (en) | 2000-07-12 | 2004-01-06 | Pharmacia & Upjohn Co. | Oxazinoquinolones useful for the treatment of viral infections |
| US6821969B2 (en) * | 2001-02-13 | 2004-11-23 | Pharmacia & Upjohn Company | Thioxazinoquinolones as antiviral agents |
| JP2005530681A (ja) * | 2001-12-20 | 2005-10-13 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ピリドキノキサリン抗ウイルス剤 |
| BR0215067A (pt) | 2001-12-20 | 2004-11-09 | Upjohn Co | Piridoquinoxalinas antivirais |
| US20040176366A1 (en) * | 2002-08-30 | 2004-09-09 | Wathen Michael W | Method of preventing or treating atherosclerosis or restenosis |
| AU2003262947A1 (en) * | 2002-08-30 | 2004-03-19 | Pharmacia And Upjohn Company | Method of preventing or treating atherosclerosis or restenosis |
| WO2005009971A1 (ja) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | キノロン誘導体又はその塩 |
| US11072610B2 (en) | 2018-09-12 | 2021-07-27 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CN114667285B (zh) | 2019-09-26 | 2025-08-08 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
| US4870168A (en) | 1987-02-26 | 1989-09-26 | Bristol-Myers Company | 3-Unsaturated alkyl cephems from 3-triflyl cephems |
| TW222276B (de) * | 1992-01-27 | 1994-04-11 | Fujisawa Pharmaceutical Co | |
| US5792774A (en) | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| AU4172197A (en) * | 1996-09-10 | 1998-04-02 | Pharmacia & Upjohn Company | 8-hydroxy-7-substituted quinolines as anti-viral agents |
-
2000
- 2000-09-08 TW TW089118456A patent/TW500724B/zh not_active IP Right Cessation
- 2000-09-15 PE PE2000000954A patent/PE20010598A1/es not_active Application Discontinuation
- 2000-09-22 AR ARP000104986A patent/AR032598A1/es unknown
- 2000-09-28 CA CA002382691A patent/CA2382691A1/en not_active Abandoned
- 2000-09-28 NZ NZ518189A patent/NZ518189A/en unknown
- 2000-09-28 DK DK00966694T patent/DK1220858T3/da active
- 2000-09-28 US US09/672,472 patent/US6340680B1/en not_active Expired - Fee Related
- 2000-09-28 DE DE60006412T patent/DE60006412T2/de not_active Expired - Fee Related
- 2000-09-28 ES ES00966694T patent/ES2210001T3/es not_active Expired - Lifetime
- 2000-09-28 EP EP00966694A patent/EP1220858B1/de not_active Expired - Lifetime
- 2000-09-28 AU AU77001/00A patent/AU773098B2/en not_active Ceased
- 2000-09-28 AT AT00966694T patent/ATE253578T1/de not_active IP Right Cessation
- 2000-09-28 JP JP2001528183A patent/JP2003511382A/ja active Pending
- 2000-09-28 WO PCT/US2000/021985 patent/WO2001025239A2/en not_active Ceased
- 2000-09-28 PT PT00966694T patent/PT1220858E/pt unknown
- 2000-10-03 CO CO00074929A patent/CO5251424A1/es not_active Application Discontinuation
-
2002
- 2002-02-25 ZA ZA200201556A patent/ZA200201556B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1220858E (pt) | 2004-03-31 |
| NZ518189A (en) | 2004-05-28 |
| WO2001025239A3 (en) | 2001-11-22 |
| AU773098B2 (en) | 2004-05-13 |
| TW500724B (en) | 2002-09-01 |
| DE60006412D1 (de) | 2003-12-11 |
| DE60006412T2 (de) | 2004-08-26 |
| WO2001025239A2 (en) | 2001-04-12 |
| AR032598A1 (es) | 2003-11-19 |
| EP1220858A2 (de) | 2002-07-10 |
| AU7700100A (en) | 2001-05-10 |
| PE20010598A1 (es) | 2001-05-24 |
| CA2382691A1 (en) | 2001-04-12 |
| CO5251424A1 (es) | 2003-02-28 |
| US6340680B1 (en) | 2002-01-22 |
| EP1220858B1 (de) | 2003-11-05 |
| DK1220858T3 (da) | 2004-01-26 |
| ZA200201556B (en) | 2003-07-30 |
| ES2210001T3 (es) | 2004-07-01 |
| JP2003511382A (ja) | 2003-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE60234760D1 (de) | Phenylindole zur behandlung von hiv | |
| ATE363904T1 (de) | Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs | |
| ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| ATE417602T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| DE69903543D1 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
| DE60022916D1 (de) | Reboxetin zur Behandlung von peripheren Neuropathien | |
| DE60219292D1 (de) | Pyrazolderivate zur behandlung von hiv | |
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| ATE265860T1 (de) | Impstoff zur behandlung von atherosclerosis | |
| DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
| DE60030554D1 (de) | Verwendungen von et743 zur behandlung von krebs | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| EP1117431A4 (de) | Behandlung von acidose | |
| ATE276262T1 (de) | Oxazinochinolone für die behandlung viraler infektionen | |
| ATE298569T1 (de) | Virus behandlung | |
| DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1220858 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |